EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy

Can Huang iD, Xuyan Zhang, Yuanyin Teng iD, Zhongsong Zhang, Bing Wang, Panpan Gu, Xiang Deng iD, Dianwen Wang, Hongli Xiao, Lingli Zou, Meng Zhao, Caifeng Zheng und 3 weitere

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s628321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Can Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The People's Hospital of Baoan, Shenzhen, Guangdong, 518101, People's Republic of China. Hauptthemen laut MEDLINE: Multiple Myeloma, Nanomedicine, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaNanomedicineImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansAnimalsPrecision MedicineB-Cell Maturation AntigenTumor MicroenvironmentNanoparticles

Stichwörter der Autor:innen

BCMACAR-T cell therapybone marrow microenvironmentmultiple myelomananomedicine

Substanzen

Receptors, Chimeric AntigenB-Cell Maturation Antigen

Autor:innen und Institutionen

  • Department of Hematology, The People's Hospital of Baoan, Shenzhen, Guangdong, 518101, People's Republic of China.
  • Department of Hematology, The Second Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, 518101, People's Republic of China.
  • Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, 310003, People's Republic of China.
  • School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, 610550, People's Republic of China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China.
  • Institute of Biomedical Sciences, Fudan University, Shanghai, 200032, People's Republic of China.

ORCID-Profile: Can Huang, Yuanyin Teng, Xiang Deng, Gaochun Zeng

Zitieren

APA

Huang, C., Zhang, X., Teng, Y., Zhang, Z., Wang, B., Gu, P., Deng, X., Wang, D., Xiao, H., Zou, L., Zhao, M., Zheng, C., Zeng, G., Li, J., & Huang, Z. (2026). Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s628321

Vancouver

Huang C, Zhang X, Teng Y, Zhang Z, Wang B, Gu P, et al. Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s628321

BibTeX
@article{Huang2026,
  author = {Huang, Can and Zhang, Xuyan and Teng, Yuanyin and Zhang, Zhongsong and Wang, Bing and Gu, Panpan and Deng, Xiang and Wang, Dianwen and Xiao, Hongli and Zou, Lingli and Zhao, Meng and Zheng, Caifeng and Zeng, Gaochun and Li, Jianyun and Huang, Zoufang},
  title = {Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s628321}
}
Kostenlos starten →